Dareon-Lung-1 will test obrixtamig plus Tecentriq and chemo in small-cell lung cancer.
ApexOnco Front Page
Recent articles
The Sentry trial hits on spleen volume reduction, but misses on symptoms.
The cash-strapped biotech adds Car-T projects but tries to avoid a lawsuit.
And AbbVie and Genmab scoop their ASH presentation with new data.
The company adds royalty aggregation to its R&D business.
But Enhertu is coming.
A new first-line maintenance phase 3 joins a relapsed pivotal phase 2 study.
The restructured biotech’s new lead project enters phase 1.
